Hims & Hers Health Inc(HIMS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -0.62 | Insider Own | 9.19% | Shs Outstand | 224.9M | Perf Week | -1.99% |
| Market Cap | 6.44B | Forward P/E | 92.48 | EPS next Y | 150.62% | Insider Trans | -1.21% | Shs Float | 211.9M | Perf Month | -6.22% |
| Enterprise Value | 7.14B | PEG | 8.64 | EPS next Q | 0.06 | Inst Own | 67% | Short Float | 25.85% | Perf Quarter | -5.9% |
| Income | -0.14B | P/S | 2.5 | EPS this Y | -215.55% | Inst Trans | 2.05% | Short Ratio | 4.69 | Perf Half Y | -6.12% |
| Sales | 2.58B | P/B | 19.86 | EPS next 5Y | 10.7% | ROA | -5.16% | Short Interest | 54.77M | Perf YTD | -15.03% |
| Book/sh | 1.39 | P/C | 7.65 | EPS past 3/5Y | - | ROE | -32.03% | 52W High | -45.89% ($50.99) | Perf Year | -43.44% |
| Cash/sh | 3.6 | P/FCF | 99.54 | Sales past 3/5Y | 64.55% 73.63% | ROIC | -7.64% | 52W Low | 100.8% ($13.74) | Perf 3Y | 353.78% |
| Dividend Est. | - | EV/EBITDA | 82.62 | EPS Y/Y TTM | -169.91% | Gross Margin | 54.19% | Volatility(W/M) | 5% 6.09% | Perf 5Y | 255.08% |
| Dividend TTM | - | EV/Sales | 2.77 | Sales Y/Y TTM | 28.04% | Oper. Margin | -0.03% | ATR (14) | 1.75 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.87 | EPS Q/Q | -320.75% | Profit Margin | -5.51% | RSI (14) | 43.79 | Recom | 2.53 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.93 | Sales Q/Q | 38.25% | SMA20 | -5.02% ($29.05) | Beta | 2.53 | Target Price | $32.15 |
| Payout | - | Debt/Eq | 4.77 | Earnings | 2026/11/9 | SMA50 | -5.27% ($29.12) | Rel Volume | 0.49 | Prev Close | $27.71 |
| Employees | 2442 | LT Debt/Eq | 4.74 | EPS/Sales Surpr. | -642.97% 7.77% | SMA200 | 1.83% ($27.09) | Avg Volume(3M) | 11.67M | Price | $27.59 |
| IPO | 2019/9/13 | Option/Short | Yes/Yes | Trades | 36261 | Volume | 5,755,611 | Change | -0.43% |
A U.S. healthcare company that operates a consumer-direct (D2C) telehealth platform. It connects patients with online consultations and prescriptions, offering personalized treatments and subscription-based products in areas such as hair loss, sexual health, weight loss, mental health, and skincare. Its performance is tied to subscriber numbers, average revenue per user, and the regulatory environment, making it a healthcare stock sensitive to those factors.
Over the past 1 year, roughly in the middle
46% below its 1-year high.
Traded less than usual. That is 49% of its average volume.
Next earnings report: November 9
13 days to go.
HIMS has weak earnings and a weak balance sheet
Of every $100 in sales, $0.03 is lost.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -215.6% this year.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $250. Peers typically go for $217.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +255.1%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Short interest is a burden
25.9% of the float is sold short.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
ULTI REX IncomeMax Option Strategy ETF 0.05% 
HEAL Global X HealthTech ETF 0.04% 
EKG First Trust Nasdaq Lux Digital Health Solutions ETF 0.03% 
IBUY Amplify Online Retail ETF 0.03% 
KYLD Kurv High Income ETF 0.03% Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
HIMZ Defiance Daily Target 2X Long HIMS ETF 54M 
HIYY YieldMax HIMS Option Income Strategy ETF 23M 
HMYY GraniteShares YieldBoost HIMS ETF - 
HIMC Corgi HIMS 2x Daily ETF - It ranks #13 of 83 in the industry
Based on market cap of $6B.
FAQ
What kind of company is HIMS?
HIMS belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is the market cap of HIMS?
The market cap of HIMS is approximately $6.4B, ranking 1,165 within its sector.
What is the 52-week high and low for HIMS?
HIMS has recorded a 52-week high of $50.99 and a low of $13.74.
